Eli Lilly and Company on Monday announced initial data over a combination treatment that shortened hospitalized coronavirus patients’ time to recovery. The drug, baricitinib (marketed as Olumiant), is ...

Australian researchers have discovered that an anti-inflammatory drug already being used to treat rheumatoid arthritis could dramatically improve recovery from heart attacks. The work is published in ...

Eli Lilly and Co said on Monday its rheumatoid arthritis drug shortened the recovery time for hospitalized COVID-19 patients also given Gilead Sciences Inc's antiviral remdesivir. Lilly said its drug, ...

Eli Lilly said Sept. 14 that its rheumatoid arthritis drug, Olumiant, in combination with remdesivir shortened recovery time by about a day for COVID-19 patients in comparison to those treated with ...

Millions worldwide, including a steep rise in India, suffer from arthritis, often diagnosed late. Early symptoms like ...

Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...